PortfoliosLab logo

Adaptive Biotechnologies Corporation (ADPT)

Equity · Currency in USD · Last updated Dec 8, 2022

Company Info

ISINUS00650F1093
CUSIP00650F109
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$7.95
Year Range$6.26 - $29.35
EMA (50)$8.12
EMA (200)$11.47
Average Volume$980.90K
Market Capitalization$1.12B

ADPTShare Price Chart


Loading data...

ADPTPerformance

The chart shows the growth of $10,000 invested in Adaptive Biotechnologies Corporation in Jun 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,973 for a total return of roughly -80.27%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%JulyAugustSeptemberOctoberNovemberDecember
14.05%
0.85%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

ADPTCompare to other instruments

Search for stocks, ETFs, and funds to compare with ADPT

Popular comparisons: ADPT vs. SPY

ADPTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-10.57%4.33%
6M14.55%-5.45%
YTD-71.67%-17.46%
1Y-68.41%-14.32%
5Y-37.54%8.97%
10Y-37.54%8.97%

ADPTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-37.85%-17.26%-3.81%-40.56%-5.21%3.45%13.23%-2.62%-20.18%9.27%12.85%-9.45%
2021-6.19%1.98%-28.83%3.33%-9.11%8.07%-10.28%-0.93%-6.42%-1.71%-21.91%7.55%
2020-0.05%-6.04%-1.14%15.23%20.90%25.01%-22.86%11.50%16.87%-5.24%4.64%22.63%
201919.85%-20.19%31.91%-39.23%-15.65%4.32%10.04%

ADPTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adaptive Biotechnologies Corporation Sharpe ratio is -0.77. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.20-1.00-0.80-0.60-0.40-0.20JulyAugustSeptemberOctoberNovemberDecember
-0.77
-0.67
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

ADPTDividend History


Adaptive Biotechnologies Corporation doesn't pay dividends

ADPTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-88.26%
-17.98%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

ADPTWorst Drawdowns

The table below shows the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adaptive Biotechnologies Corporation is 90.76%, recorded on Oct 14, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.76%Jan 25, 2021436Oct 14, 2022
-68.3%Sep 5, 2019133Mar 16, 2020188Dec 10, 2020321
-27.29%Jul 1, 201925Aug 5, 201918Aug 29, 201943
-14.85%Dec 24, 20207Jan 5, 20217Jan 14, 202114
-2.05%Dec 15, 20201Dec 15, 20202Dec 17, 20203
-0.85%Jan 15, 20211Jan 15, 20211Jan 19, 20212
-0.71%Jan 20, 20211Jan 20, 20212Jan 22, 20213

ADPTVolatility Chart

Current Adaptive Biotechnologies Corporation volatility is 88.74%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%JulyAugustSeptemberOctoberNovemberDecember
88.74%
22.83%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)